Global Custom Market Research Reports Provider Company


Relmada Therapeutics Inc (RLMDD) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America

Relmada Therapeutics Inc (Relmada Therapeutics), formerly known as Camp Nine, Inc is a clinical stage specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system (CNS) diseases. Its product pipeline includes REL-1017 d-Methadone, an antagonist for the treatment of neuropathic pain; REL-1028 BuTab, an oral tablet form of buprenorphine; REL-1015 LevoCap ER, an abuse resistant form of broad spectrum opioid levorphanol; and REL-1021 MepiGel, a topical gel dosage form of local anesthetic mepivacaine. Relmada Therapeutics also develops analgesics and anti-arthritic medicines. Its target treatment areas include chronic pain due to cancer, musculoskeletal disorders and peripheral neuropathy. Relmada Therapeutics is headquartered in New York, the US.

Relmada Therapeutics Inc Key Recent Developments

Jun 28,2017: Relmada Therapeutics appoints new chair of scientific advisory board
Jun 21,2017: Relmada Therapeutics appoints new executive clinical advisor
Jun 15,2017: Charles J. Casamento Appointed Chairman of Relmada Therapeutics Board of Directors
May 18,2017: Relmada Therapeutics Announces Settlement of Legal Action with Laidlaw & Company
Sep 14,2016: Relmada Therapeutics Files Amended Complaint Against Laidlaw and Its Principals, Matthew Eitner and James Ahern

This comprehensive SWOT profile of Relmada Therapeutics Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Relmada Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents

Section 1 - About the Company

Relmada Therapeutics Inc - Key Information

Relmada Therapeutics Inc - Overview

Relmada Therapeutics Inc - Key Employees

Relmada Therapeutics Inc - Key Employee Biographies

Relmada Therapeutics Inc - Key Operational Heads

Relmada Therapeutics Inc - Major Products and Services

Relmada Therapeutics Inc - History

Relmada Therapeutics Inc - Company Statement

Relmada Therapeutics Inc - Locations And Subsidiaries

Relmada Therapeutics Inc - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2 - Company Analysis

Relmada Therapeutics Inc - Business Description

Relmada Therapeutics Inc - Corporate Strategy

Relmada Therapeutics Inc - SWOT Analysis

SWOT Analysis - Overview

Relmada Therapeutics Inc - Strengths

Relmada Therapeutics Inc - Weaknesses

Relmada Therapeutics Inc - Opportunities

Relmada Therapeutics Inc - Threats

Relmada Therapeutics Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Relmada Therapeutics Inc - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 - Appendix



Ratio Definitions

About GlobalData

Contact Us


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

Relmada Therapeutics Inc, Key Information

Relmada Therapeutics Inc, Key Ratios

Relmada Therapeutics Inc, Share Data

Relmada Therapeutics Inc, Major Products and Services

Relmada Therapeutics Inc, History

Relmada Therapeutics Inc, Key Employees

Relmada Therapeutics Inc, Key Employee Biographies

Relmada Therapeutics Inc, Key Operational Heads

Relmada Therapeutics Inc, Other Locations

Relmada Therapeutics Inc, Subsidiaries

Relmada Therapeutics Inc, Key Manufacturing facilities

Relmada Therapeutics Inc, Key Competitors

Relmada Therapeutics Inc, SWOT Analysis

Relmada Therapeutics Inc, Ratios based on current share price

Relmada Therapeutics Inc, Annual Ratios

Relmada Therapeutics Inc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures

Relmada Therapeutics Inc, Performance Chart

Relmada Therapeutics Inc, Ratio Charts

Relmada Therapeutics Inc (Relmada Therapeutics), formerly known as Camp Nine, Inc is a clinical stage specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system

View Report

Relmada Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile market research report at USD 250 and market update available at JSB Market Research.

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports